{
    "clinical_study": {
        "@rank": "84022", 
        "arm_group": {
            "arm_group_label": "Endovascular", 
            "arm_group_type": "Other", 
            "description": "Device: Custom-made Zenith\u00ae Fenestrated AAA Endovascular Graft. Instead of making a large incision in the abdomen,the physician makes two small incisions in the groin. Through these incision the devices are placed into the aorta.\nOther names:\nEndovascular stent Stent-graft"
        }, 
        "brief_summary": {
            "textblock": "This study will compare two groups of subjects with complex abdominal aortic aneurysms. It\n      will compare their clinical outcomes and quality of life measures. The group being treated\n      in this study will have their aneurysms repaired by an endovascular approach using Zenith\u00ae\n      Fenestrated AAA Endovascular Graft. This group will be compared to a group of 461 patients\n      (historical cohort) whose complex aneurysms were treated by open surgical repair."
        }, 
        "brief_title": "Complex Aortic Aneurysm Repair With Fenestrated Stent Grafts", 
        "completion_date": {
            "#text": "December 2018", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Juxtarenal Aortic Aneurysms", 
            "Suprarenal Aortic Aneurysms", 
            "Type IV Thoracoabdominal Aortic Aneurysms"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Aortic Aneurysm", 
                "Aortic Aneurysm, Abdominal", 
                "Aortic Aneurysm, Thoracic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "General Inclusion Criteria\n\n        A patient may be included in the study if the patient has at least one of the following\n        and is appropriate for treatment with a custom-made Zenith\u00ae Fenestrated AAA Endovascular\n        Graft:\n\n          -  Juxtarenal, suprarenal or type IV thoracoabdominal aortic aneurysm with a diameter \u2265\n             5.0 cm or 2 times the normal aortic diameter\n\n          -  Aneurysm with a history of growth \u2265 0.5 cm per year.\n\n          -  Saccular aneurysms deemed at significant risk for rupture based upon physician\n             interpretation.\n\n        General Exclusion Criteria\n\n          -  Less than 18 years of age\n\n          -  Unwilling to comply with the follow-up schedule\n\n          -  Inability or refusal to give informed consent by the patient or a legally authorized\n             representative\n\n          -  Pregnant or breastfeeding\n\n          -  Life expectancy < 2-years\n\n          -  Additional medical restrictions as specified in the Clinical Investigation Plan\n\n          -  Additional anatomical restrictions as specified in the Clinical Investigation Plan"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01937949", 
            "org_study_id": "13-002880"
        }, 
        "intervention": {
            "arm_group_label": "Endovascular", 
            "description": "The graft will be inserted through arteries in the leg (called endovascular repair).  Endovascular repair is a procedure that uses catheters that go inside your blood vessel to place a stent graft above and below the aneurysm.  This procedure lines the aneurysm with a new lining (stent) so blood does not fill the artery any more.", 
            "intervention_name": "Custom-made Zenith\u00ae Fenestrated AAA Endovascular Graft:", 
            "intervention_type": "Device", 
            "other_name": [
                "Endovascular stent", 
                "Stent-graft"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "Aortic aneurysm", 
        "lastchanged_date": "April 9, 2014", 
        "location": {
            "contact": {
                "last_name": "Gustavo Oderich, MDd", 
                "phone": "507-284-1575"
            }, 
            "contact_backup": {
                "last_name": "Jan Hofer, RN", 
                "phone": "507-284-1575"
            }, 
            "facility": {
                "address": {
                    "city": "Rochester", 
                    "country": "United States", 
                    "state": "Minnesota", 
                    "zip": "55905"
                }, 
                "name": "Mayo Clinic in Rochester"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Clinical Outcomes and Quality of Life Measures in Patients Treated for Complex Abdominal Aortic Aneurysms With Fenestrated Stent Grafts.", 
        "overall_official": {
            "affiliation": "Mayo Clinic", 
            "last_name": "Gustavo Oderich, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Number of Subjects Who Die", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Number of Subjects Who Experience a Major Adverse Event", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01937949"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mayo Clinic", 
            "investigator_full_name": "Gustavo S. Oderich", 
            "investigator_title": "Investigator/Sponor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Subjects completed the SF-36 which consists of 8 sub-scales  which are additionally summarized into 2 summary components (physical and mental). The subscales and the summary scales both range from 0 to 100, with (0 = worst imaginable, 100 = best imaginable).", 
                "measure": "Subject Scores on Short Form-36 (SF-36) Quality of Life Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "baseline, 6 weeks, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years."
            }, 
            {
                "description": "Treatment success is defined by a composite end-point, which includes all the following criteria described below:\nTechnical success, defined as successful delivery and deployment of the custom-made endovascular graft with preservation of those branch vessels intended to be preserved.\nFreedom from type I or III endoleak.\nFreedom from stent-graft migration.\nFreedom from aneurysm enlargement >5mm\nFreedom from aneurysm rupture or conversion to open repair.", 
                "measure": "Number of Subjects Who Achieve Treatment Success", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "Mayo Clinic", 
        "sponsors": {
            "collaborator": {
                "agency": "Cook", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Mayo Clinic", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}